A citation-based method for searching scientific literature

Olga Rodak, Manuel David Peris-Díaz, Mateusz Olbromski, Marzenna Podhorska-Okołów, Piotr Dzięgiel. Cancers (Basel) 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Single-cell screening of multiple biophysical properties in leukemia diagnosis from peripheral blood by pure light scattering.
David Dannhauser, Domenico Rossi, Mimmo Ripaldi, Paolo A Netti, Filippo Causa. Sci Rep 2017
12
33

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
33

[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.
Antonio Nappi, Rosj Gallicchio, Vittorio Simeon, Anna Nardelli, Alessandra Pelagalli, Angela Zupa, Giulia Vita, Angela Venetucci, Michele Di Cosola, Francesco Barbato,[...]. Radiol Oncol 2015
12
33

Biology and clinical significance of circulating tumor cell subpopulations in lung cancer.
Linda O'Flaherty, Harriet Wikman, Klaus Pantel. Transl Lung Cancer Res 2017
18
33


Nanotechnology and pancreatic cancer management: State of the art and further perspectives.
Damiano Caputo, Daniela Pozzi, Tommaso Farolfi, Roberto Passa, Roberto Coppola, Giulio Caracciolo. World J Gastrointest Oncol 2021
2
50

CD4+ versus CD8+ T-lymphocyte identification in an integrated microfluidic chip using light scattering and machine learning.
Domenico Rossi, David Dannhauser, Mariarosaria Telesco, Paolo A Netti, Filippo Causa. Lab Chip 2019
7
33

Nanoparticle-biomolecular corona: A new approach for the early detection of non-small-cell lung cancer.
Marina Di Domenico, Daniela Pozzi, Sara Palchetti, Luca Digiacomo, Rosamaria Iorio, Carlo Astarita, Alfonso Fiorelli, Matteo Pierdiluca, Mario Santini, Marcella Barbarino,[...]. J Cell Physiol 2019
11
33

Biophysical investigation of living monocytes in flow by collaborative coherent imaging techniques.
David Dannhauser, Domenico Rossi, Pasquale Memmolo, Andrea Finizio, Pietro Ferraro, Paolo Antonio Netti, Filippo Causa. Biomed Opt Express 2018
6
33

Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule.
Manhua Zhong, Yi Zhang, Zuguang Pan, Wei Wang, Yuxin Zhang, Yuqing Weng, Haile Huang, Yanju He, Ouqi Liu. Technol Cancer Res Treat 2021
1
100

Proteomics analysis of human serum of patients with non-small-cell lung cancer reveals proteins as diagnostic biomarker candidates.
Mariarosaria Boccellino, Federica Pinto, Vincenzo Ieluzzi, Alfonso Giovane, Lucio Quagliuolo, Chiara Fariello, Mario Coppola, Annalisa Carlucci, Mario Santini, Kenan Ferati,[...]. J Cell Physiol 2019
8
33

Refining the treatment of NSCLC according to histological and molecular subtypes.
Anish Thomas, Stephen V Liu, Deepa S Subramaniam, Giuseppe Giaccone. Nat Rev Clin Oncol 2015
179
33

Global Epidemiology of Lung Cancer.
Julie A Barta, Charles A Powell, Juan P Wisnivesky. Ann Glob Health 2019
297
33

Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
Yang Li, Xudong Tian, Lei Gao, Xiaohong Jiang, Rao Fu, Tingting Zhang, Tianying Ren, Ping Hu, Yaping Wu, Peige Zhao,[...]. Cancer Med 2019
17
33

Optical signature of erythrocytes by light scattering in microfluidic flows.
D Dannhauser, D Rossi, F Causa, P Memmolo, A Finizio, T Wriedt, J Hellmers, Y Eremin, P Ferraro, P A Netti. Lab Chip 2015
26
33

Cluster circulating tumor cells in surgical cases of lung cancer.
Noriyoshi Sawabata, Yoshiyuki Susaki, Takahito Nakamura, Takeshi Kawaguchi, Motoaki Yasukawa, Shigeki Taniguchi. Gen Thorac Cardiovasc Surg 2020
11
33

Label-free analysis of mononuclear human blood cells in microfluidic flow by coherent imaging tools.
David Dannhauser, Domenico Rossi, Pasquale Memmolo, Filippo Causa, Andrea Finizio, Pietro Ferraro, Paolo A Netti. J Biophotonics 2017
7
33

Efficient pancreatic cancer detection through personalized protein corona of gold nanoparticles.
Luca Digiacomo, Damiano Caputo, Roberto Coppola, Chiara Cascone, Francesca Giulimondi, Sara Palchetti, Daniela Pozzi, Giulio Caracciolo. Biointerphases 2021
1
100

Lung Cancer Biomarkers.
Hoseok I, Je-Yoel Cho. Adv Clin Chem 2015
55
33

Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer.
Vilem Maly, Ondrej Maly, Katarina Kolostova, Vladimir Bobek. In Vivo 2019
22
33

The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments.
Daniel Di Capua, Dara Bracken-Clarke, Karine Ronan, Anne-Marie Baird, Stephen Finn. Cancers (Basel) 2021
1
100

Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery.
Ana Lilia Barrán-Berdón, Daniela Pozzi, Giulio Caracciolo, Anna Laura Capriotti, Giuseppe Caruso, Chiara Cavaliere, Anna Riccioli, Sara Palchetti, Aldo Laganà. Langmuir 2013
166
33

A comprehensive analysis of liposomal biomolecular corona upon human plasma incubation: The evolution towards the lipid corona.
Giorgia La Barbera, Anna Laura Capriotti, Giulio Caracciolo, Chiara Cavaliere, Andrea Cerrato, Carmela Maria Montone, Susy Piovesana, Daniela Pozzi, Erica Quagliarini, Aldo Laganà. Talanta 2020
9
33

Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.
Parisa Malekzadeh, Anna Pasetto, Paul F Robbins, Maria R Parkhurst, Biman C Paria, Li Jia, Jared J Gartner, Victoria Hill, Zhiya Yu, Nicholas P Restifo,[...]. J Clin Invest 2019
89
33

CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells.
Guangchao Li, Jintao Guo, Yanfang Zheng, Wen Ding, Zheping Han, Lingyu Qin, Wenjun Mo, Min Luo. Mol Ther Oncolytics 2021
1
100

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.
T A Chan, M Yarchoan, E Jaffee, C Swanton, S A Quezada, A Stenzinger, S Peters. Ann Oncol 2019
575
33


Chimeric antigen receptor T cells for sustained remissions in leukemia.
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
33

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.
Robert D Schreiber, Lloyd J Old, Mark J Smyth. Science 2011
33


New strategies in lung cancer: translating immunotherapy into clinical practice.
Patrick M Forde, Ronan J Kelly, Julie R Brahmer. Clin Cancer Res 2014
32
33

Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Ziying Lin, Lixia Huang, ShaoLi Li, Jincui Gu, Xiaoxian Cui, Yanbin Zhou. Sci Rep 2020
6
33

Aldo-keto reductase (AKR) superfamily: genomics and annotation.
Rebekka D Mindnich, Trevor M Penning. Hum Genomics 2009
81
33

Novel prognostic molecular markers in lung cancer.
Michał Puderecki, Justyna Szumiło, Barbara Marzec-Kotarska. Oncol Lett 2020
8
33

Clinicopathologic Characteristics of BRG1-Deficient NSCLC.
Ibiayi Dagogo-Jack, Alexa B Schrock, Marina Kem, Nicholas Jessop, Jessica Lee, Siraj M Ali, Jeffrey S Ross, Jochen K Lennerz, Alice T Shaw, Mari Mino-Kenudson. J Thorac Oncol 2020
24
33

Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer.
Corrin A Wohlhieter, Allison L Richards, Fathema Uddin, Christopher H Hulton, Àlvaro Quintanal-Villalonga, Axel Martin, Elisa de Stanchina, Umeshkumar Bhanot, Marina Asher, Nisargbhai S Shah,[...]. Cell Rep 2020
20
33


Conserved pan-cancer microenvironment subtypes predict response to immunotherapy.
Alexander Bagaev, Nikita Kotlov, Krystle Nomie, Viktor Svekolkin, Azamat Gafurov, Olga Isaeva, Nikita Osokin, Ivan Kozlov, Felix Frenkel, Olga Gancharova,[...]. Cancer Cell 2021
25
33

SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition.
Joao V Alessi, Biagio Ricciuti, Liam F Spurr, Hersh Gupta, Yvonne Y Li, Carolyn Glass, Mizuki Nishino, Andrew D Cherniack, James Lindsay, Bijaya Sharma,[...]. J Thorac Oncol 2021
5
33

Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.
Michael J Grant, Roy S Herbst, Sarah B Goldberg. Nat Rev Clin Oncol 2021
7
33

NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming.
Kate E Hawkins, Shona Joy, Juliette M K M Delhove, Vassilios N Kotiadis, Emilio Fernandez, Lorna M Fitzpatrick, James R Whiteford, Peter J King, Juan P Bolanos, Michael R Duchen,[...]. Cell Rep 2016
90
33

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.
Elisabeth Brambilla, Gwénaël Le Teuff, Sophie Marguet, Sylvie Lantuejoul, Ariane Dunant, Stephen Graziano, Robert Pirker, Jean-Yves Douillard, Thierry Le Chevalier, Martin Filipits,[...]. J Clin Oncol 2016
176
33

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas.
Natasha Rekhtman, Joseph Montecalvo, Jason C Chang, Deepu Alex, Ryan N Ptashkin, Ni Ai, Jennifer L Sauter, Brie Kezlarian, Achim Jungbluth, Patrice Desmeules,[...]. J Thorac Oncol 2020
62
33

Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors.
Jim Middelburg, Kristel Kemper, Patrick Engelberts, Aran F Labrijn, Janine Schuurman, Thorbald van Hall. Cancers (Basel) 2021
10
33

An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
Elisa Dama, Valentina Melocchi, Fabio Dezi, Stefania Pirroni, Rose Mary Carletti, Daniela Brambilla, Giovanni Bertalot, Monica Casiraghi, Patrick Maisonneuve, Massimo Barberis,[...]. Clin Cancer Res 2017
18
33

Oxidative Stress in Cancer.
John D Hayes, Albena T Dinkova-Kostova, Kenneth D Tew. Cancer Cell 2020
183
33

Recent advances in the molecular landscape of lung neuroendocrine tumors.
Giuseppe Pelosi, Fabrizio Bianchi, Paul Hofman, Linda Pattini, Philipp Ströbel, Fiorella Calabrese, Salma Naheed, Chloe Holden, Judith Cave, Hanibal Bohnenberger,[...]. Expert Rev Mol Diagn 2019
16
33

NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes.
Anju Singh, Anneleen Daemen, Dorothee Nickles, Sang-Min Jeon, Oded Foreman, Kuladeep Sudini, Florian Gnad, Stephane Lajoie, Naina Gour, Wayne Mitzner,[...]. Clin Cancer Res 2021
20
33

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.
Ming Sound Tsao, Keith M Kerr, Mark Kockx, Mary-Beth Beasley, Alain C Borczuk, Johan Botling, Lukas Bubendorf, Lucian Chirieac, Gang Chen, Teh-Ying Chou,[...]. J Thorac Oncol 2018
356
33

Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC.
Francesco Facchinetti, Aurélien Marabelle, Giulio Rossi, Jean-Charles Soria, Benjamin Besse, Marcello Tiseo. J Thorac Oncol 2016
20
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.